Attard, C., Brown, S., Alloul, K., & Moore, M. (2014). Cost-effectiveness of folfirinox for first-line treatment of metastatic pancreatic cancer. Multimed Inc.
Παραπομπή Chicago StyleAttard, C.L., S. Brown, K. Alloul, και M.J Moore. Cost-effectiveness of Folfirinox for First-line Treatment of Metastatic Pancreatic Cancer. Multimed Inc, 2014.
Παραπομπή MLAAttard, C.L., S. Brown, K. Alloul, και M.J Moore. Cost-effectiveness of Folfirinox for First-line Treatment of Metastatic Pancreatic Cancer. Multimed Inc, 2014.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.